Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.

As a promising target for the treatment of lung cancer, the MutT Homolog 1 (MTH1) protein can be inhibited by crizotinib. A recent work shows that the inhibitory potency of (S)-crizotinib against MTH1 is about 20 times over that of (R)-crizotinib. But the detailed molecular mechanism remains unclear...

Full description

Bibliographic Details
Main Authors: Yuzhen Niu, Dabo Pan, Danfeng Shi, Qifeng Bai, Huanxiang Liu, Xiaojun Yao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4683072?pdf=render
id doaj-01116b6a0c334b09bb18db25eeecc2b3
record_format Article
spelling doaj-01116b6a0c334b09bb18db25eeecc2b32020-11-25T01:45:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014521910.1371/journal.pone.0145219Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.Yuzhen NiuDabo PanDanfeng ShiQifeng BaiHuanxiang LiuXiaojun YaoAs a promising target for the treatment of lung cancer, the MutT Homolog 1 (MTH1) protein can be inhibited by crizotinib. A recent work shows that the inhibitory potency of (S)-crizotinib against MTH1 is about 20 times over that of (R)-crizotinib. But the detailed molecular mechanism remains unclear. In this study, molecular dynamics (MD) simulations and free energy calculations were used to elucidate the mechanism about the effect of chirality of crizotinib on the inhibitory activity against MTH1. The binding free energy of (S)-crizotinib predicted by the Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) and Adaptive biasing force (ABF) methodologies is much lower than that of (R)-crizotinib, which is consistent with the experimental data. The analysis of the individual energy terms suggests that the van der Waals interactions are important for distinguishing the binding of (S)-crizotinib and (R)-crizotinib. The binding free energy decomposition analysis illustrated that residues Tyr7, Phe27, Phe72 and Trp117 were important for the selective binding of (S)-crizotinib to MTH1. The adaptive biasing force (ABF) method was further employed to elucidate the unbinding process of (S)-crizotinib and (R)-crizotinib from the binding pocket of MTH1. ABF simulation results suggest that the reaction coordinates of the (S)-crizotinib from the binding pocket is different from (R)-crizotinib. The results from our study can reveal the details about the effect of chirality on the inhibition activity of crizotinib to MTH1 and provide valuable information for the design of more potent inhibitors.http://europepmc.org/articles/PMC4683072?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Yuzhen Niu
Dabo Pan
Danfeng Shi
Qifeng Bai
Huanxiang Liu
Xiaojun Yao
spellingShingle Yuzhen Niu
Dabo Pan
Danfeng Shi
Qifeng Bai
Huanxiang Liu
Xiaojun Yao
Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.
PLoS ONE
author_facet Yuzhen Niu
Dabo Pan
Danfeng Shi
Qifeng Bai
Huanxiang Liu
Xiaojun Yao
author_sort Yuzhen Niu
title Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.
title_short Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.
title_full Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.
title_fullStr Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.
title_full_unstemmed Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations.
title_sort influence of chirality of crizotinib on its mth1 protein inhibitory activity: insight from molecular dynamics simulations and binding free energy calculations.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description As a promising target for the treatment of lung cancer, the MutT Homolog 1 (MTH1) protein can be inhibited by crizotinib. A recent work shows that the inhibitory potency of (S)-crizotinib against MTH1 is about 20 times over that of (R)-crizotinib. But the detailed molecular mechanism remains unclear. In this study, molecular dynamics (MD) simulations and free energy calculations were used to elucidate the mechanism about the effect of chirality of crizotinib on the inhibitory activity against MTH1. The binding free energy of (S)-crizotinib predicted by the Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) and Adaptive biasing force (ABF) methodologies is much lower than that of (R)-crizotinib, which is consistent with the experimental data. The analysis of the individual energy terms suggests that the van der Waals interactions are important for distinguishing the binding of (S)-crizotinib and (R)-crizotinib. The binding free energy decomposition analysis illustrated that residues Tyr7, Phe27, Phe72 and Trp117 were important for the selective binding of (S)-crizotinib to MTH1. The adaptive biasing force (ABF) method was further employed to elucidate the unbinding process of (S)-crizotinib and (R)-crizotinib from the binding pocket of MTH1. ABF simulation results suggest that the reaction coordinates of the (S)-crizotinib from the binding pocket is different from (R)-crizotinib. The results from our study can reveal the details about the effect of chirality on the inhibition activity of crizotinib to MTH1 and provide valuable information for the design of more potent inhibitors.
url http://europepmc.org/articles/PMC4683072?pdf=render
work_keys_str_mv AT yuzhenniu influenceofchiralityofcrizotinibonitsmth1proteininhibitoryactivityinsightfrommoleculardynamicssimulationsandbindingfreeenergycalculations
AT dabopan influenceofchiralityofcrizotinibonitsmth1proteininhibitoryactivityinsightfrommoleculardynamicssimulationsandbindingfreeenergycalculations
AT danfengshi influenceofchiralityofcrizotinibonitsmth1proteininhibitoryactivityinsightfrommoleculardynamicssimulationsandbindingfreeenergycalculations
AT qifengbai influenceofchiralityofcrizotinibonitsmth1proteininhibitoryactivityinsightfrommoleculardynamicssimulationsandbindingfreeenergycalculations
AT huanxiangliu influenceofchiralityofcrizotinibonitsmth1proteininhibitoryactivityinsightfrommoleculardynamicssimulationsandbindingfreeenergycalculations
AT xiaojunyao influenceofchiralityofcrizotinibonitsmth1proteininhibitoryactivityinsightfrommoleculardynamicssimulationsandbindingfreeenergycalculations
_version_ 1725022544403103744